Viewing nowUnilova Tablet 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

MFDS item code 201605331 · Approved 2016.08.31 · Insurance code 669804830
Improves dyslipidemia, inhibits the progression of atherosclerosis, and reduces cardiovascular disease risk
This medication is an adjunct used in patients with primary hypercholesterolemia and mixed dyslipidemia when not controlled by diet alone and exercise. It also effectively lowers serum cholesterol levels when administered in conjunction with diet or other lipid-lowering therapies in patients with homozygous familial hypercholesterolemia. In patients with hypercholesterolemia, it plays a role in delaying the progression of atherosclerosis by lowering total cholesterol and LDL cholesterol to target levels. It is also used as an adjunct to diet in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, reducing total cholesterol and LDL cholesterol levels. Additionally, it is used as an adjunct to diet for patients with primary dysbetalipoproteinemia. Most importantly, this medication helps reduce the risk of stroke, myocardial infarction, and vascular revascularization in middle-aged patients with high-sensitivity C-reactive protein levels and cardiovascular disease risk factors. Overall, this medication is effectively used for the prevention and treatment of hypercholesterolemia and related cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this drug and continue it throughout the treatment period. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this drug at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. 6. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of this drug at a dose of 40 milligrams is contraindicated in some of these patients.
Age 10 ~ 17 years: The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) The dose should be individualized according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy have not been established.
This medication should not be administered to certain patients. For example, it should not be used in patients allergic to any ingredient of this medication, those with severe liver function problems, patients with muscle-related disorders, and those taking specific medications. Women who are pregnant, breastfeeding, or of childbearing potential should have a thorough consultation regarding the risk of pregnancy and effects on the fetus before taking this medication. It is important to regularly check liver function and muscle condition while taking this medication. Patients with a history of liver disease, those who consume excessive alcohol, have hypothyroidism, or have impaired kidney function should be especially cautious. If symptoms such as muscle pain, weakness, or cramps occur, medical personnel should be notified immediately, and this medication can be discontinued if necessary. Additionally, after intense exercise, muscle enzyme test results may be affected, so caution is required during testing. This medication can raise blood sugar levels in some patients; therefore, those at risk for diabetes should undergo regular testing related to blood sugar. There may be interactions with other medications; therefore, current medications should be disclosed to medical personnel, especially when combined with specific antiviral drugs, immunosuppressants, antifungals, and fibrate-type medications. The use of this medication is not recommended during pregnancy or breastfeeding, and women planning to become pregnant should use appropriate contraceptive methods. In case of overdose, since no specific antidote exists, treatment should follow the symptoms while monitoring liver function and muscle enzyme levels. This medication may cause symptoms such as dizziness, so caution is needed when driving or operating machinery. Finally, if severe skin rashes, fever, or systemic symptoms indicating severe skin reactions occur while taking this medication, use should be discontinued immediately, and consultation with medical personnel is required.
Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, severe muscle weakness, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, elevated CK, elevated AST, joint pain, fatigue, numbness, paraesthesia, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, acute renal failure, oliguria, elevated serum creatinine
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.
Yellow round film-coated tablet
For domestic use - 30 tablets/bottle, For export - 30 tablets/box [(10 tablets/PTP x 3)], For export - 100 tablets/box [(10 tablets/PTP x 10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.